Is Neurothera Labs Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Neurothera Labs Inc (NTLX.V) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Neurothera Labs Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Neurothera Labs Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Neurothera Labs Inc?

Muslim investors may consider investing in Neurothera Labs Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Neurothera Labs Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Neurothera Labs Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Neurothera Labs Inc updated?

The Shariah compliance status of Neurothera Labs Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Neurothera Labs Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Neurothera Labs Inc?

You can check the latest Shariah compliance status of Neurothera Labs Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Neurothera Labs Inc. Stock Analysis NTLX.V

Canada N/A Nano Cap

Neurothera Labs Inc. operates as a specialty clinical-stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-07-19. The firm is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in various drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation, and SCI- 210 for the treatment of ASD and status epilepticus.

Key Statistics of Neurothera Labs Inc (NTLX.V)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.19CAD0.26

Today's Open

CAD0.19

Volume

9000.00

P/E Ratio (TTM)

52 Week Range

CAD0.16CAD0.26

Market Cap

5.42M

Avg. Volume

16.50K

Dividend Yield

Financial Metrics & Statements of Neurothera Labs Inc (NTLX.V)

FAQ's for Neurothera Labs Inc (NTLX.V)

According to Musaffa’s Shariah screening methodology, Neurothera Labs Inc (NTLX.V) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.